Communicable disease threats report, 5 - 11 November 2023, week 45
WHO releases step by step guide to help countries develop their national genomic surveillance strategy for pathogens with pandemic and epidemic potential
ECDC publishes epidemiological update on increased COVID-19 transmission, SARS-CoV-2 variants, and public health considerations for autumn 2023
Epidemiological update: COVID-19 transmission in the EU/EEA, SARS-CoV-2 variants, and public health considerations for Autumn 2023
Communique on SARS-CoV-2 BA.2.86 sub-variant – Africa CDC
Respiratory Virus Toolkit
Ending the COVID-19 emergency and transitioning from emergency phase to longer-term disease management: guidance on calibrating the response, 4 September 2023
Weekly epidemiological update on COVID-19 - 13 July 2023
Donors making a difference: building stronger health systems
Lessons From COVID-19 for Protecting Workers in the Next Pandemic
Genomic Surveillance for SARS-CoV-2 Variants: Circulation ...
The Mass COVID-19 vaccination Campaign in the Democratic Republic of Congo reaches over 300,000 people – Africa CDC
With the international public health emergency ending, WHO/Europe launches its transition plan for COVID-19
Toward a deeper understanding of long COVID
ECDC-EMA statement on updating COVID-19 vaccines composition for new SARS-CoV-2 virus variants
Developing a global research agenda for public health and social measures: Research priorities for COVID-19
Covid-19: WHO treaty on future pandemics is being watered down, warn health leaders
Variants of the Virus COVID-19 Data Monitoring the impact of COVID-19 and
Prevention Strategies and Treatments for COVID-19
Covid-19: WHO declares end of global health emergency
The Transition Beyond the Acute Phase of COVID-19 Pandemic in Africa – Africa CDC
NIH study identifies features of Long COVID neurological symptoms
Guidance on operational microplanning for COVID-19 vaccination, revised 2 May 2023
ECDC presents lessons learned from the COVID-19 pandemic
Global Compendium of Knowledge on COVID-19
COVID-19 Vaccine Insights Report - 11 April 2023
Autumn vaccination campaigns focused on older age groups and other high-risk populations are key to decrease impact of COVID-19
Drugs to prevent COVID-19: living guideline
Conducting after-action reviews of the public health response to COVID-19
Regional workshop on COVID-19 recovery in Tunisia
COVID-19 vaccination is rising in many vulnerable African communities thanks to EU-funded, WHO-led project
EPI-WIN webinars, World Health Organization's information network for epidemics webinars on COVID-19
Africa CDC Annual Report 2021 – Africa CDC
NIH RECOVER research identifies potential long COVID disparities
Covid-19: Evusheld is unlikely to prevent infection with current or future variants, NICE concludes
NIH trial to evaluate Shionogi antiviral in adults hospitalized with COVID-19
Lingering symptoms common after COVID hospitalization
Covid-19: WHO treaty hopes to overcome "catastrophic failures" of pandemic response
COVID-19: Pacific Community Updates
Protecting infants through covid-19 vaccination during pregnancy
WHO EPI-WIN webinar: Current COVID-19 situation and what's next for COVID-19
Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers - Repository - Public Health Scotland
International Pandemic Preparedness Secretariat Releases New Report; NAM President Victor Dzau Co-Chairs IPPS Scientific Advisory Group - National Academy of Medicine
Core protocol for ECDC studies of COVID-19 vaccine effectiveness against hospitalisation with Severe Acute Respiratory Infection, laboratory-confirmed with SARS-CoV-2 or with seasonal influenza - Version 2.0
Protocol for a COVID-19 vaccine effectiveness study using health data registries
Update 83: The Global Influenza Outbreak - What we are doing and what it means for pandemic influenza
Laboratory-Confirmed COVID-19 Case Incidence Rates ...
Three years of pandemic learning response: reaching learners across the world with life-saving health knowledge
Early Estimates of Bivalent mRNA Booster Dose Vaccine ...
Covid-19: Vaccination plus infection offers best protection, finds study led by WHO
Reasons for Receiving or Not Receiving Bivalent COVID ...
WHO Webinar Series on Trust and Pandemic Preparedness: Webinar 1: Trust and pandemics
Covid-19: What do we know about XBB.1.5 and should we be worried?
WHO Policy Brief: Gatherings in the context of COVID-19, 19 January 2023
Public health management of possible cases - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
COVID-19 Symptoms 6 Months After Onset and the Role of Vaccination for SARS-CoV-2 Infection
How are covid-19 symptoms changing?
Most long covid effects resolve within a year after mild infection | BMJ
National Emergency Department Visits for COVID-19, Influenza, and Respiratory Syncytial Virus | CDC
Introduction - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Contacts of confirmed cases of COVID-19 - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Management of COVID-19 outbreaks - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Checklist for COVID-19 outbreaks - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Vaccination - COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
COVID-19 PCR testing network scaled down
Better recognition for research participants: what society should learn from covid-19
COVID-19 - guidance for health protection teams (HPTs) - version 2.6 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
WHO/BS/2022.2426 Rev: A Collaborative Study to Evaluate the Proposed 1st WHO International Standard for SARS-CoV-2 Antigen
WHO welcomes data on COVID-19 in China, meeting with Minister
Rapid recommendation: A living WHO guideline on drugs for covid-19
Call for Expression of Interest: Scoping review of Science and Knowledge Translation in health emergency policy-making
E-learning: COVID-19 infodemic management: risk communication and community engagement challenges, by WHO
ECDC assesses risk to the EU/EEA associated with Omicron XBB1.5 sub-lineage
Threat Assessment Brief: Implications for the EU/EEA of the spread of the SARS-CoV-2 Omicron XBB.1.5 sub-lineage
WHO updates COVID-19 guidelines on masks, treatments and patient care
The generic all-hazards risk assessment and planning tool for mass gathering events
Pilot study outline for targeted genomic surveillance of SARS-CoV-2 in travellers in response to a worsening or unknown epidemiological situation in a third country
Infection prevention and controlin the context of coronavirus disease (COVID-19): A living guideline
Clinical management of COVID-19: Living guideline, 13 January 2023
Therapeutics and COVID-19: Living guideline, 13 January 2023
Safety and monitoring for patients receiving Nirmatrelvir-ritonavir for COVID-19
Administration of Nirmatrelvir-ritonavir for COVID-19
Nirmatrelvir-ritonavir for COVID-19
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5–11 Years — United States, October 12–January 1, 2023
Developing mucosal vaccines for respiratory viruses
WHO Director-General's opening remarks at the media briefing – 11 January 2023
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 18 December 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Weekly national respiratory infection and COVID-19 statistical report 11 January 2023 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland
Latest data on respiratory infections in Scotland - News - Public Health Scotland
COVIDGuidance.org
Outliving the virus: various reasons for COVID-19 vaccination
EASA/ECDC provide guidelines for aviation as part of European response to COVID-19 developments in China
Guidelines in response to the worsening of the epidemiological situation - Addendum to the Aviation Health Safety Protocol
Paxlovid reduces serious risks from Omicron variants
UKHSA begins testing arrivals from China to enhance detection of new variants
Cancer and COVID-19 | CDC
Statement – Science, surveillance, responsibility: the essentials to addressing the ongoing COVID-19 challenge
Engaging Community Leaders in Zambia's COVID-19 Response
Precautionary and temporary measures to improve COVID surveillance from China
NIH funds eight studies to advance rapid diagnosis of COVID-19-related inflammatory syndrome in children
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 21 December 2022
Protecting the workforce through influenza and COVID-19 vaccination: perspectives from Greece
Weekly national respiratory infection and COVID-19 statistical report 6 January 2023 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland
Advisory group urges countries to prioritize protecting the most vulnerable with COVID-19 vaccination and integrate COVID-19 vaccination into routine health-care strategies
NIH launches Home Test to Treat, a pilot COVID-19 telehealth program
Racial and Ethnic Differences in COVID-19 Vaccination Coverage Among Children and Adolescents Aged 5–17 Years and Parental Intent to Vaccinate Their Children — National Immunization Survey–Child COVID Module, United States, December 2020–September 2022
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 11 December 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Update on SARS-CoV-2 variants: ECDC assessment of the XBB.1.5 sub-lineage
Communicable disease threats report, 2-8 January 2023, week 1
With CDC Support, Uganda Improves Emergency Medical Services During COVID-19 Pandemic | CDC
WHO Director-General's opening remarks at the media briefing – 4 January 2023
TAG-VE statement on the 3rd January meeting on the COVID-19 situation in China
Communique on the Sudden Increase in COVID-19 Cases driven by the Omicron BF.7 Variants – Africa CDC
COVID-19 vaccine for children after MIS-C appears safe
Covid-19: Doctors are asked to help track variants among people arriving from China
Covid-19: China stops counting cases as models predict a million or more deaths
Impact of surge in China COVID-19 cases on epidemiological situation in EU/EEA
Back to school advice issued amid high levels of flu, COVID-19 and scarlet fever
Aircraft Operators/Airlines/Crew FAQs Requirements for Negative Pre-departure COVID-19 Test Result or Documentation of Recovery from COVID-19 for Aircraft Passengers Traveling to the United States from the People's Republic of China | Quarantine | CDC
WHO meets with Chinese officials on current COVID-19 situation
Precautionary and temporary measures introduced to improve Covid surveillance from China
Solomon Islands Medical Assistance Team and WHO rapidly deploy to support Temotu Province's COVID-19 outbreak response
Coronavirus Test Device Approvals (CTDA): statutory review of process
Statutory review of the Coronavirus Test Device Approvals (CTDA) process
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 04 December 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Training on handling, storing and transporting Pfizer-BioNTech COVID-19 mRNA Vaccine COMIRNATY® (Tozinameran)
Technical guidance
Case management
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 7 December 2022
COVID-19 Response Fund
Uganda Treats COVID-19 Patients in National Soccer Stadium | CDC
U.S. CDC in Uganda and Partners Bring COVID-19 Vaccines to Local Populations | CDC
COVID-19: UKHSA laboratory assessments of inactivation methods
Covid-19: Molnupiravir does not cut hospital admissions or deaths in vaccinated people at high risk, trial finds
Gift yourself a life-saving vaccine this Christmas holiday
Communicable disease threats report, 18-24 December 2022, week 51
Product Information Leaflet (PIL) for VidPrevtyn Beta dispersion for injection
Outbreak Brief 153: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Papua New Guinea: The one-on-one personal approach goes to work for COVID-19 protection
WHO Director-General's opening remarks at the media briefing – 21 December 2022
Weekly epidemiological update on COVID-19 - 21 December 2022
Nursing Home COVID-19 Vaccination Data Dashboard | NHSN | CDC
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 27 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Regulatory approval of COVID-19 vaccine VidPrevtyn Beta
Weekly national respiratory infection and COVID-19 statistical report 21 December 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland
Sanofi Pasteur COVID-19 vaccine authorised by MHRA
COVID-19 surveillance and study protocols
North Macedonia's caravan: bringing COVID-19 vaccines and information about influenza and other vaccines to communities
Communicable disease threats report, 11 - 17 December 2022, week 50
The COVID-19 risk communication package for community members in various settings
Episode #88 - Living with COVID-19
Long Term Care Facilities Enrolling in CDC COVID-19 Vaccination Program | CDC
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
Mask and outbreak guidance updated in care settings
Prevalence of SARS-CoV-2 and Influenza Coinfection and Clinical Characteristics Among Children and Adolescents Aged <18 Years Who Were Hospitalized or Died with Influenza — United States, 2021–22 Influenza Season
ECDC expert consultation on the implementation and evaluation of non-pharmaceutical interventions
Evaluation of medicines to prevent COVID-19
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 20 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Weekly national respiratory infection and COVID-19 statistical report 14 December 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland
CDC Expands Updated COVID-19 Vaccines to Include Children Ages 6 Months through 5 Years
Episode #14 - COVID-19 - Tests
Risk of severe pressure on healthcare systems due to RSV, flu and COVID-19 co-circulation
Outbreak Brief 150: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Last updated 12/2022 - Summary of Product Characteristics Comirnaty 3 micrograms/dose concentrate for ages 6 months to 4 years (maroon cap)
CDC collaborates with South Africa to strengthen border health during COVID-19 l CDC
Covid-19: Winter surge feared as China lurches away from zero covid
Communicable disease threats report, 4 – 10 December 2022, week 49
Despite continued impact of COVID-19, malaria cases and deaths remained stable in 2021
Haiti: Hospitals face critical oxygen shortages and warn of lack of fluids to treat cholera
Weekly national respiratory infection and COVID-19 statistical report 7 December 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 13 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
In Denmark, people roll up their sleeves for seasonal influenza and COVID-19 vaccines
Scottish COVID-19 Contact Tracing Programme - COVID-19 - Respiratory infections - Conditions and diseases - Our areas of work - Public Health Scotland
Performance of lateral flow devices during the COVID-19 pandemic
Communicable disease threats report, 27 November – 3 December 2022, week 48
Getting vaccines to those who need them most: Albania launches autumn influenza campaign and begins to roll out COVID-19 booster doses
POD Assist Features and Benefits
HIV Services and Outcomes During the COVID-19 Pandemic — United States, 2019–2021
SARS-CoV-2 Serology and Self-Reported Infection Among Adults — National Health and Nutrition Examination Survey, United States, August 2021–May 2022
COVID-19 disruptions in HIV testing and prevention highlight need for innovation and investment before the next public health emergency
Joint statement - Influenza season epidemic kicks off early in Europe as concerns over RSV rise and COVID-19 is still a threat
Technical report on the COVID-19 pandemic in the UK
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 6 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Weekly national respiratory infection and COVID-19 statistical report 30 November 2022 - Weekly national respiratory infection and COVID-19 statistical report - Publications - Public Health Scotland
Covid-19: Protests against lockdowns in China reignite amid crackdown
Report a COVID-19 rapid lateral flow test result
One year of Omicron: the vital work of a WHO reference lab in the surveillance and diagnosis of viruses
Health experts collaborate to provide support to Tuvalu amidst COVID-19 outbreak
Prevention, identification and management of infections in health workers in the context of COVID-19
Outbreak Brief 149: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
COVID-19 surveillance: planned changes to how vaccination data is presented
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 9 November 2022
Women leaders in North Macedonia build trust in COVID-19 vaccination
One year since the emergence of COVID-19 virus variant Omicron
COVID-19 statistical report - 23 November 2022 - COVID-19 statistical report - Publications - Public Health Scotland
‘Mass testing' linked to 25% cut in covid-19 related hospital admissions | BMJ
Testing & Management Flu and SARS-COV-2 in Nursing Homes
Weekly national seasonal respiratory report - Week 46 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland
COVID-19 NMA Summary Report
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 30 October 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Investigation of SARS-CoV-2 variants: technical briefings
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
NIH establishes website for self-reporting COVID-19 test results
Paxlovid Associated with Decreased COVID-19 Hospitalizations ..
Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts, version 2.0
Covid-19: "Grotesque inequity" that only a quarter of paxlovid courses go to poorer countries
Fiji, the UN and partners deploy medical personnel and supplies in solidarity with Tuvalu's COVID-19 response effort
Communicable disease threats report, 13-19 November 2022, week 46
Covid-19: Is the UK still tracking the virus—and other questions answered
New study details work-related COVID-19 exposure among non-healthcare workers
Perception of Local COVID-19 Transmission and Use of Preventive Behaviors Among Adults with Recent SARS-CoV-2 Infection — Illinois and Michigan, June 1–July 31, 2022
Sociodemographic Variation in Early Uptake of COVID-19 Vaccine ..
Differences in COVID-19 Hospitalizations by Self-Reported Race and Ethnicity in a Hospital in Honolulu, Hawaii
Africa CDC, in collaboration with ASLM, FIND, and CHAI, launched a Consultative Workshop on Revised COVID-19 Testing and Surveillance Strategy – Africa CDC
NHS COVID-19 app statistics
Studies provide latest ‘real world' evidence on effectiveness of covid-19 treatments | BMJ
Outbreak Brief 148: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
COVID-19 statistical report - 16 November 2022 - COVID-19 statistical report - Publications - Public Health Scotland
We should be proud of our pandemic response in the Pacific – let's build upon it to save lives now and in future
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 23 October 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
COVID-19 Vaccine Delivery Partnership - October 2022
Covid-19: China eases rules amid rise in cases
WHO's Infection prevention & control department
CDC South Africa supports vaccination against COVID-19 | CDC
Covid-19: NICE rejects five treatments over uncertain evidence and price in draft guidance
USAID and WHO Provide US $2 million in Medical Supplies to Fight COVID-19 and Other Diseases
Phylogenetic Analysis of SARS-CoV-2 in Ontario | Public Health Ontario
Vaccination after SARS-CoV-2 infection linked to a decrease in long covid symptoms | BMJ
Covid-19: Funding for pandemic preparedness being "sucked away" by war in Ukraine
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 26 October 2022
The Africa Union COVID-19 Vaccination BINGWA Initiative | Africa CDC initiative to speed and scale up COVID-19 vaccination in Africa – Africa CDC
COVID-19 Surge Testing Sites of the ICATT Program | CDC
South-East Asia Region - Weekly Situation Reports
Communicable disease threats report, 6-12 November 2022, week 45
Outbreak Brief 147: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
COVID-19 Clinical Care Pathway
COVID-19–Associated Hospitalizations Among U.S. Infants Aged <6 Months — COVID-NET, 13 States, June 2021–August 2022
Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
Vaccine access: World's poorest people suffer at the hands of free market dynamics, says WHO
COVID-19 statistical report - 9 November 2022 - COVID-19 statistical report - Publications - Public Health Scotland
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 9 November 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Covid-19: Evusheld protects the most vulnerable patients, analysis shows
National flu and COVID-19 surveillance reports: 2021 to 2022 season
Emerging Fairer & Stronger from COVID-19: Health System Imperatives - National Academy of Medicine
Preventing and managing outbreaks of acute respiratory illness (ARI) in the Children and Young People Secure Estate (CYPSE)
United States Provides Pediatric Pfizer Vaccines to Protect Children from COVID-19
Guidance for Maritime Vessels on the Mitigation and Management of COVID-19 | Quarantine | CDC
Pregnancy and coronavirus (COVID-19)
COVID-19 outreach programmes to migrant workers: evaluating VCSOs role
COVID-19 and TB
COVID-19 Mortality by Occupation and Industry
WHO Director-General's opening remarks at 12th ACT Accelerator Facilitation Council Meeting – 28 October 2022
WHO Director-General's opening remarks at Member State Information Session on COVID-19 and other issues – 27 October 2022
ACT-Accelerator launches six month plan as world transitions to long-term COVID-19 control
TAG-VE statement on Omicron sublineages BQ.1 and XBB
Notes From the Field: Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–Level Social Vulnerability — United States, December 23, 2021–August 28, 2022 | MMWR
Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 ― United States, January–July 2022 | MMWR
About SAGE and COVID-19 - GOV.UK
Tuberculosis deaths and disease increase during the COVID-19 pandemic
RKI - Unit 32: Surveillance - Systematic Surveillance for SARS-CoV-2 in wastewater
Weekly epidemiological update on COVID-19 - 26 October 2022
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 2 October 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
COVID-19 statistical report - 26 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland
CDC and Tanzania Speed Up COVID-19 Vaccinations | CDC
Getting a Flu Vaccine and a COVID-19 Vaccine at the Same Time | CDC
COVID-19
Laboratory support for SARS-CoV-2 virus neutralisation in the EU/EEA - a pilot study
Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing
Outbreak Brief 144: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Spread of the SARS-CoV-2 Omicron variant sub-lineage BQ.1 in the EU/EEA
World Health Organization (WHO) response to the External Evaluation of the Access to COVID-19 Tools Accelerator (ACT-A)
New Omicron sub-lineage likely to cause further increase in covid-19 cases
Call for Applications: African Union (AU) COVID-19 Vaccination Bingwa Initiative – Eastern Africa Region – Africa CDC
Effectiveness of Monovalent mRNA Vaccines Against COVID-19–Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States — IVY Network, 18 States, December 26, 2021–August 31, 2022 | MMWR
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022 | MMWR
Building next generation sequencing capacity for SARS-CoV-2 through workforce strengthening in Kyrgyzstan
Management and safe disposal of COVID-19 vaccination waste at health facility level
Statement on the thirteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 25 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
COVID-19 statistical report - 19 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland
COVID-19 vaccination: a guide on pregnancy and breastfeeding - GOV.UK
4 things to know about COVID-19 treatment in the Pacific
Q&A: Influenza in the context of COVID-19
Integrating SARS-CoV-2 and influenza surveillance in Timor-Leste
COVID-19 statistical report - 12 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland
Covid-19: Booster vaccines rolled out as hospital admissions rise | The BMJ
Weekly national seasonal respiratory report - Week 40 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland
WHO-WIPO-WTO Workshop : Innovation and Access to diagnostics for COVID-19 and beyond
Communicable disease threats report, 9-15 October 2022, week 41
Outbreak Brief 143: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
USAID Provides $1.5 Million for COVID-19 Vaccine Rollout Support in Lao PDR
External Evaluation of the Access To COVID-19 Tools Accelerator (ACT-A)
WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues – 13 October 2022
WHO Director-General's opening remarks at the 13th meeting of the IHR Emergency Committee on COVID-19 pandemic – 13 October 2022
Building COVID-19 Vaccine Confidence in Minnesota's Prisons and Jails | CDC
Solidarity clinical trial for COVID-19 treatments
Donors making a difference: The European Union teams up with WHO to boost COVID-19 vaccination coverage in Africa
Joint statement: Working together towards COVID-19 and seasonal influenza vaccinations for this winter
COVID-19 response in the Philippines | WHO Philippines
Community leaders in Georgia called upon to promote COVID-19 vaccination
Weekly national seasonal respiratory report - Week 39 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland
COVID-19 PPE guide for adult social care services and settings - GOV.UK
Covid-19: Antiviral purchased by UK government does not lower risk of hospital admission, trial shows | The BMJ
Covid-19: Hospital admissions rise in England as some trusts reinstate mask requirements | The BMJ
Evusheld: Government is urged to expedite covid antibody treatment for vulnerable patients | The BMJ
Decision on Evusheld as a COVID-19 treatment - GOV.UK
Media Professionals from West Africa Region Trained on Infodemic Management and Data Journalism for a Better COVID-19 Response – Africa CDC
WHO EPI-WIN Webinar: What we know about influenza and COVID-19
COVID-19 statistical report - 5 October 2022 - COVID-19 statistical report - Publications - Public Health Scotland
WHO Director-General's opening remarks at the media briefing – 5 October 2022
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 11 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Outbreak Brief 142: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Supporting Individual Risk Assessment during COVID-19 |The National Academies Press
COVID-19 Scientific and Public Health Policy Update (28 September 2022) – Africa CDC
COVID-19 Strategic Preparedness and Response Plan 2022: Global Monitoring and Evaluation Framework
Communicable disease threats report, 25 September - 1 October 2022, week 39
Working hand in hand to manage COVID‑19 laboratory quality
COVID-19 - information and guidance for social, community and residential care settings - version 2.4 - COVID-19 - information and guidance for social, community and residential care settings (including care homes for older people registered with the Care Inspectorate) - Publications - Public Health Scotland
Similarities and Differences between Flu and COVID-19 | CDC
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents — 19 States, March 29–July 25, 2022 | MMWR
COVID-19 Vaccine Delivery Partnership - August 2022
Monthly operational update on COVID-19 - September 2022
COVID-19 statistical report - 28 September 2022 - COVID-19 statistical report - Publications - Public Health Scotland
New dashboard presents integrated data on winter flu and COVID-19 vaccine programme - News - Public Health Scotland
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 4 September 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
Health and safety during COVID-19: training for health workers in south-eastern Europe
WHO's response to COVID-19 - 2022 Mid-Year Report
The EU experience in the first phase of COVID-19: implications for measuring preparedness
The WHO global infodemic manager community of practice is growing and tackling COVID-19, monkeypox and other outbreaks
WHO Director-General's opening remarks at the COVID-19 Global Action Plan Ministerial Meeting, New York, USA - 23 September 2022
WHO Director-General's opening remarks at the UNGA UNSG-hosted event: "Ending the pandemic through equitable access to COVID-19 vaccines, tests and treatments" – 23 September 2022
Why we are changing our COVID-19 reporting - Our blog - Public Health Scotland
Safety and side effects - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Conditions and diseases - Our areas of work - Public Health Scotland
Guidance for General Population Disaster Shelters During the COVID-19 Pandemic | CDC
Covid-19: Cases rise in England and Wales as hospital admissions remain steady | The BMJ
COVID-19 health protection guidance - COVID-19 - Conditions and diseases - Our areas of work - Public Health Scotland
ACT-Accelerator Facilitation Council Working Group Report on Diagnostics and Therapeutics
No time for COVID-19 complacency, say key countries responsible for tracking global rollout of COVID-19 vaccines, tests and treatments
Call To Action: Africa's New Public Health – Africa CDC
National protocol for Comirnaty® Original/Omicron BA.1 (15/15 micrograms)/dose COVID-19 mRNA vaccine - GOV.UK
COVID-19 Test to Treat Guidelines for African Union Member States – Africa CDC
Therapeutics and COVID-19: Living guideline, 16 September 2022
Reporting Adverse Events Following Vaccination | Vaccine Safety | CDC
COVID-19 Scientific and Public Health Policy Update (14 September 2022) – Africa CDC
400 000 doses of Comirnaty vaccine delivered to Ukraine under COVAX
Pilot protocol for a COVID-19 vaccine effectiveness study using health data registries
A continent-wide collaboration on genomics surveillance show the power of African science and how the majority of COVID-19 variants were introduced into Africa – Africa CDC
COVID-19 Wastewater Surveillance in Ontario | Public Health Ontario
WHO strongly advises against antibody treatments for covid-19 patients | BMJ
Reflecting on the implementation of genomic surveillance for COVID-19 and beyond in the African Region
COVID-19 - information and guidance for social, community and residential care settings - version 2.3 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland
WHO Director-General's opening remarks at the launch of The Lancet COVID-19 Commission Final Report – 15 September 2022
Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022 | MMWR
Clinical management of COVID-19: Living guideline, 15 September 2022
Syndromic surveillance summary: 15 September 2022 week 36 - GOV.UK
NIH-funded team develops method to identify future SARS-CoV-2 mutations that could affect rapid antigen test performance | National Institutes of Health (NIH)
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 21 August 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
A guide to the COVID-19 autumn booster - GOV.UK
Covid-19: Commission describes "massive global failures" of pandemic response | The BMJ
WHO policy brief: Reaching COVID-19 vaccination targets, 14 September 2022
WHO policy brief: Maintaining infection prevention and control measures for COVID-19 in health care facilities, 14 September 2022
WHO policy brief: Building trust through risk communication and community engagement, 14 September 2022
WHO policy brief: COVID-19 infodemic management, 14 September 2022
WHO policy brief: COVID-19 testing, 14 September 2022
WHO policy brief: Clinical management of COVID-19, 14 September 2022
COVID-19 policy briefs
FAQs on Reporting COVID-19 Vaccination Data | NHSN | CDC
WHO Director-General's opening remarks at the 72nd Session of the WHO Regional Committee for Europe – 12 September 2022
HM Prison and Probation Service COVID-19 Statistics, August 2022 - GOV.UK
Resilience of age-friendly environments during the COVID-19 pandemic: lessons learnt from 12 European cities
Ireland tracks its way to COVID-19 vaccine delivery success
COVID-19 Activity in Ontario: Ontario COVID-19 Science Advisory Table Dashboard Indicator Roadmap | Public Health Ontario
Novavax COVID-19 vaccine Nuvaxovid approved by MHRA - GOV.UK
Eligible groups - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Our areas of work - Public Health Scotland
Outbreak Brief 138: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Uganda's Disease Detectives: Integral to Stopping the Spread of COVID-19 | Division of Global Health Protection | Global Health | CDC
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 14 August 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Parental Intentions and Perceptions Toward COVID-19 Vaccination Among Children Aged 4 Months to 4 Years — PROTECT Cohort, Four States, July 2021–May 2022 | MMWR
Actions to strengthen resilience of health workers in south-eastern Europe in response to COVID-19 and beyond: implementation of WHO/ILO guidance and mapping of priority needs for occupational health and safety programmes for health workers
Access community-based treatments for coronavirus (COVID-19) - GOV.UK
COVID-19: recommendations on use of adapted vaccines
Investing in the COVID-19 Response through the ACT-Accelerator: Long-Term Benefits
Africa CDC and Partners mobilize National EPI Managers and other Stakeholders to accelerate COVID-19 vaccination in Africa. – Africa CDC
Regulatory approval of Pfizer/BioNTech bivalent Original/Omicron booster vaccine - GOV.UK
Priorities, actions and technical support of the IPC pillar of the regional COVID-19 Incident Management Support Team
US and Canada to roll out the first omicron specific boosters within days | The BMJ
COVID-19 Vaccine Delivery Partnership - July 2022
Communicable disease threats report, 28 August-3 September 2022, week 35
Recommendations from the WHO Technical Advisory Group on Safe Schooling During the COVID-19 Pandemic: revised version following the eighth TAG meeting, 20 January 2022
CDC Recommends the First Updated COVID-19 Booster | CDC Online Newsroom | CDC
COVID-19 mRNA Vaccine Safety Among Children Aged 6 Months–5 Years — United States, June 18, 2022–August 21, 2022 | MMWR
Booster COVID-19 Vaccinations Among Persons Aged ≥5 Years and Second Booster COVID-19 Vaccinations Among Persons Aged ≥50 Years — United States, August 13, 2021–August 5, 2022 | MMWR
Travel ban implemented to protect public health following Denmark COVID-19 mink outbreak - GOV.UK
WHO Director-General's opening remarks at media briefing – 31 August 2022
Covid alert level reduced to two - GOV.UK
COVID-19 vaccination programme - GOV.UK
Statement: Control, elimination, eradication: three actions we need to take on three different public health emergencies in the European Region in the coming months
Monthly operational update on COVID-19 - August 2022
WHO Director-General's opening remarks at 12th meeting of the Technical Advisory Group on Behavioural Insights and Sciences for Health– 30 August 2022
5000 micro-influencers in Portugal build confidence in COVID-19 vaccination
EPI-WIN webinar: Omicron BA.5: What do we know about new COVID variants of concern?
SARS-CoV-2 antigen levels linked to patient outcomes | National Institutes of Health (NIH)
Long-term qualitative scenarios and considerations of their implications for preparedness and response to the COVID-19 pandemic in the EU/EEA
The COVID-19 Risk Communication Package For Healthcare Facilities
COVID-19: epidemiological update. Weekly report. Week 33. 25 August 2022.
NIH-funded pediatric COVID-19 testing study finds school-aged children can self-swab | National Institutes of Health (NIH)
Communicable disease threats report, 21-27 August, week 34
Laboratory-Confirmed COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Omicron BA.2 Variant Predominance — COVID-19–Associated Hospitalization Surveillance Network, 14 States, June 20, 2021–May 31, 2022 | MMWR
Promising practices and lessons learnt in the South-East Asia Region in accessing medical oxygen during the COVID-19 pandemic
Covid-19: Asymptomatic testing is "paused" in England's hospitals and care homes | The BMJ
WHO Director-General's opening remarks at the COVID-19 media briefing– 25 August 2022
COVID-19 and other respiratory viruses: mitigating their spread as children return to school across Europe
Annexes to the interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF
COVID-19: testing during periods of low prevalence - GOV.UK
Regular asymptomatic testing paused in additional settings - GOV.UK
COVID Infection Survey - GOV.UK
Generic protocol for COVID-19 vaccine effectiveness studies at long-term care facilities in the EU/EEA
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
100 000 doses of the Janssen vaccine delivered to Ukraine under COVAX
US CDC announces major changes after criticism of its responses to covid-19 and monkeypox | The BMJ
Background document on the Valneva VLA2001 vaccine against COVID-19
CDC Recommends Novavax COVID-19 Vaccine for Adolescents | CDC Online Newsroom | CDC
WHO Director-General's opening remarks at the 72nd session of the Regional Committee for Africa – 22 August 2022
African Union COVID-19 Vaccination Bingwa Initiative – Africa CDC
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 24 July 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Call for public consultation - Target Product Profile (TPP) for readers of rapid diagnostic tests (RDT readers)
COVID-19: epidemiological update. Weekly report. Week 32. 18 August 2022.
Covid-19: Results from India's 12 molnupiravir clinical trials remain unpublished | The BMJ
Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022 | MMWR
COVID-19 Outbreaks and Mortality Among Public Transportation Workers — California, January 2020–May 2022 | MMWR
Safety Monitoring of Pfizer-BioNTech COVID-19 Vaccine Booster Doses Among Children Aged 5–11 Years — United States, May 17–July 31, 2022 | MMWR
Annexes to the recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19
Annexes to the recommendations for use of the Pfizer–BioNTech vaccine BNT162b2 against COVID-19
Transition of COVID-19 Hospital Reporting | NHSN | CDC
Clinical characteristics of COVID-19
Covid-19: What have been the direct and indirect health impacts in England? | The BMJ
Covid-19: UK will roll out Moderna's omicron BA.1 vaccine as part of autumn booster programme | The BMJ
Fighting current and future coronaviruses with a single vaccine | National Institutes of Health (NIH)
Winter vaccine resources for healthcare workers - Publications - Public Health Scotland
COVID-19: Effectiveness and benefits of vaccination - Canada.ca
Covid-19: UK will not buy Evusheld owing to "insufficient data" on protection, government says | The BMJ
JCVI publishes advice on COVID-19 vaccines for autumn booster programme - GOV.UK
COVID-19: the green book, chapter 14a - GOV.UK
Lab Advisory: FDA Advises Repeat Testing to Reduce False Negative Results with COVID-19 Antigen Tests
Covid-19: Study provides further evidence that mRNA vaccines are safe in pregnancy | The BMJ
Benefits of Getting A COVID-19 Vaccine | CDC
CDC streamlines COVID-19 guidance to help the public better protect themselves and understand their risk | CDC Online Newsroom | CDC
Outbreak Brief 134: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
COVID-19 Self-Test Data: Challenges and Opportunities — United States, October 31, 2021–June 11, 2022 | MMWR
Notes from the Field: School-Based and Laboratory-Based Reporting of Positive COVID-19 Test Results Among School-Aged Children — New York, September 11, 2021–April 29, 2022 | MMWR
Interim statement on COVID-19 vaccination for children
Clinical management of COVID-19
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 17 July 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
COVID-19 vaccine guide for youth and adults: Managing COVID-19 vaccine administration errors or deviations - Canada.ca
COVID-19 Scientific and Public Health Policy Update – (03 August 2022) – Africa CDC
Advisory Committee on Immunization Practices (ACIP) Work Groups | CDC
Statement from the Chief Public Health Officer of Canada on August 5, 2022 - Canada.ca
Janssen Jcovden® (Johnson & Johnson) COVID-19 vaccine - Canada.ca
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 20 July 2022 - GOV.UK
Management of critical COVID-19 Advanced non-invasive respiratory support: high-flow nasal oxygen and non-invasive ventilation- Part 2
Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022 | MMWR
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE): Novavax COVID-19 Vaccine
Supporting the deployment of COVID-19 vaccines and routine vaccination systems in the Eastern Partnership: Armenia
Outbreak Brief 133: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
ASPHER - Member's blog - Other
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 10 July 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 3 August 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Unity Studies: Early Investigation Protocols
Methods for the detection and characterisation of SARS-CoV-2 variants - second update
References | Toward a Post-Pandemic World: Lessons from COVID-19 for Now and the Future: Proceedings of a Workshop |The National Academies Press
Summary of Product Characteristics for Vaxzevria - GOV.UK
Covid-19: Ontario hospitals close wards as nursing shortage bites | The BMJ
COVID-19: guidance for health professionals - GOV.UK
Communicable disease threats report, 24-30 July, week 30
ECDC expert consultation on knowledge and research gaps related to the COVID-19 public health response
Coronavirus disease (COVID-19) and people living with HIV
Patient information for Paxlovid - GOV.UK
Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022 | MMWR
Report of the Commission on Human Medicines Expert Working Group on COVID-19 vaccine safety surveillance - GOV.UK
Syndromic surveillance summary: 28 July 2022 week 29 - GOV.UK
GRADE: Moderna COVID-19 Vaccine for Persons Aged 12-17 Years | CDC
GRADE: Moderna COVID-19 Vaccine for Children Aged 6-11 Years | CDC
ACIP Evidence to Recommendations for Use of Moderna COVID-19 Vaccine in Children Ages 6 – 17 Years under an Emergency Use Authorization | CDC
Outbreak Brief 132: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
WHO Director-General's opening remarks at the COVID-19 media briefing– 27 July 2022
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Monthly operational update on COVID-19 - July 2022
Communicable disease threats report, 17 - 23 July, week 29
Communicable disease threats report, 3-9 July 2022, week 27
Communicable disease threats report, 26 June-2 July 2022, week 26
WHO Director-General's opening remarks at the media briefing – 29 June 2022
Communicable disease threats report, 12-18 June 2022, week 24
WHO Director-General's opening remarks at the COVID-19 media briefing– 14 June 2022
Communicable disease threats report, 5-11 June 2022, week 23
Remarks from the Chief Public Health Officer, June 3, 2022 - Canada.ca
WHO Director-General's opening remarks at the COVID-19 media briefing – 8 June 2022
Communicable disease threats report, 29 May -4 June 2022, week 22
Communicable disease threats report, 8-14 May 2022, week 19
Covid-19: BA.5 variant is now dominant in US as infections rise | The BMJ
New study updates evidence on rare heart condition after covid vaccination | BMJ
Covid-19: High prevalence and lack of hospital beds putting "intense pressure" on ambulances | The BMJ
WHO advises against use of two drugs for non-severe covid-19 | BMJ
Covid-19: Researchers face wait for patient level data from Pfizer and Moderna vaccine trials | The BMJ
Covid-19: Parts of England see hospital admissions more than double in two weeks | The BMJ
Covid-19: Hospitals and GP clinics return to universal mask wearing as rates rise | The BMJ
Covid vaccines: Canada to dispose of 13.6 million AstraZeneca doses owing to lack of demand | The BMJ
Covid-19: FDA authorises pharmacists to prescribe Paxlovid | The BMJ
Covid-19: WHO urges countries to plug immunity gaps as global infections rise | The BMJ
Covid-19: GPs are asked to opt into next vaccination phase this autumn | The BMJ
New review of evidence highlights importance of ventilation to prevent spread of covid-19 | BMJ
Wearable activity trackers + AI can pick up presymptomatic COVID-19 | BMJ
Covid-19: CDC and FDA approve Pfizer and Moderna vaccines for under 5s | The BMJ
Covid-19: Omicron sub variants driving new wave of infections in UK | The BMJ
Covid-19: Long covid risk is lower with omicron than delta, researchers find | The BMJ
Covid-19: Second boosters may benefit at-risk groups but have "minimal" impact for others, says WHO | The BMJ
Covid-19: Two million people in the UK are estimated to be experiencing long covid, says ONS | The BMJ
Covid-19: True global death toll from pandemic is almost 15 million, says WHO | The BMJ
Covid-19: JCVI advises further booster for vulnerable adults and health and care workers | The BMJ
Covid-19: WHO chief calls for a shift in China's "unsustainable" policy | The BMJ
Covid-19: Fourth dose of mRNA vaccines is safe and boosts immunity, study finds | The BMJ
Covid-19: Symptomatic infection with omicron variant is milder and shorter than with delta, study reports | The BMJ
Covid-19: Mask mandate is struck down although US cases are rising | The BMJ
Covid-19: UK adds sore throat, headache, fatigue, and six other symptoms to official list | The BMJ
Vaccine resources in other languages and alternative formats - COVID-19 vaccine information and resources - COVID-19 vaccinations - COVID-19 - Our areas of work - Public Health Scotland
Data at WHO
Personal Protective Equipment (PPE) portal - GOV.UK
Using the WHO online COVID-19 public health and social measures calibration tool: a step-by-step guide
RKI - COVID-19 - Interrupt chains of infection digitally with the Corona-Warn-App
Outbreak Brief 131: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Number of COVID-19 tests in defence and positive cases in the UK Armed Forces 2022 - GOV.UK
Guiding the evaluation of COVID-19 vaccine effectiveness
Public health surveillance for COVID-19: interim guidance
Global surveillance of COVID-19: WHO process for weekly reporting aggregated data
COVID-19 guidance for prison settings - version 2.1 - COVID-19 guidance for prison settings - Publications - Public Health Scotland
Africa CDC Saving Lives and Livelihoods Initiative Commences Implementation in Kenya – Africa CDC
Revised case report form for confirmed Novel Coronavirus COVID-19 (report to WHO within 48 hours of case identification)
COVID-19 testing in homelessness, domestic abuse refuge and respite room settings - GOV.UK
Global COVID-19 Vaccination Strategy in a Changing World: July 2022 update
WHO releases global COVID-19 vaccination strategy update to reach unprotected
Final WHO SARS-CoV-2 serology test kit evaluation results
Tracking SARS-CoV-2 variants in wastewater | National Institutes of Health (NIH)
COVID-19: Support to provinces and territories - Canada.ca
WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues - 21 July 2022
Weekly national seasonal respiratory report - Week 28 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland
Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Approved or Authorized in the United States
Guidance for Cruise Ships on the Mitigation and Management of COVID-19 | Quarantine | CDC
Statement from NIH and BARDA on the Novavax COVID-19 Vaccine | National Institutes of Health (NIH)
WHO Director-General's opening remarks at the COVID-19 media briefing– 20 July 2022
WHO supports strengthening of whole genome sequencing capacity at Universiti Sains Malaysia in Kelantan State
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 20 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
COVID-19 Vaccines for Long-term Care Residents | CDC
CDC Recommends Novavax's COVID-19 Vaccine for Adults | CDC Online Newsroom | CDC
Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time | National Institutes of Health (NIH)
Genomic sequencing used to investigate university halls outbreak in new study - News - Public Health Scotland
Rapidly escalating COVID-19 cases amid reduced virus surveillance forecasts a challenging autumn and winter in the WHO European Region
WHO Director-General's remarks at COVID-19 Global Action Plan Foreign Ministerial Meeting – 19 July 2022
Outbreak Brief 130: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Fiji: Listening leads to more impactful communication and a stronger COVID-19 response
Free vaccinations for Ukrainian refugees in the Republic of Moldova
ECDC releases publications on COVID-19 vaccination strategies and joint ECDC-WHO report on considerations for respiratory diseases as guidance for the second half of the year
Preliminary public health considerations for COVID-19 vaccination strategies in the second half of 2022
Operational considerations for respiratory virus surveillance in Europe
Weekly epidemiological update on COVID-19 - 15 June 2022
Joint Committee on Vaccination and Immunisation (JCVI) updated statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK
Côte d'Ivoire Receives COVID-19 Rapid Response Training | Division of Global Health Protection | Global Health | CDC
New COVID-19 Vaccine Effectiveness Data Showcase Protection Gained by 3rd and 4th Doses | CDC Online Newsroom | CDC
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022 | MMWR
Remarks from the Deputy Chief Public Health Officer, July 14, 2022 - Canada.ca
Over 50s to be offered COVID-19 booster and flu jab this autumn - GOV.UK
Health Canada authorizes use of Moderna COVID-19 vaccine in children 6 months to 5 years of age - Canada.ca
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022 | MMWR
The Eastern Mediterranean Region reflects on genomic sequencing and its future within integrated surveillance of respiratory viruses
Moderna Spikevax COVID-19 vaccine - Canada.ca
Weekly all-cause mortality surveillance: 2022 to 2023 - GOV.UK
The WHO Global Clinical Platform for COVID-19
Interferon treatment may reduce severity of COVID-19 in people with certain genetic factors | National Institutes of Health (NIH)
Government of Canada is re-establishing mandatory random testing offsite of airports for air travellers - Canada.ca
Therapeutics and COVID-19: living guideline
Statement from Health Canada on Decommissioning COVID Alert - Canada.ca
FAQ: COVID-19 Vaccine - Canada.ca
Interim recommendations on COVID-19 vaccination in autumn 2022 for the WHO European Region: conclusions and recommendations of the European Technical Advisory Group of Experts on Immunization
Weekly Epidemiological Update on COVID-19 - 13 July 2022
Patient Information Leaflet for COVID-19 Vaccine Valneva - GOV.UK
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 13 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Expert advisory group recommends COVID-19 vaccination strategy for the autumn season
COVID-19 Reverses Progress in Fight Against Antimicrobial Resistance in U.S. | CDC Online Newsroom | CDC
WHO Director-General's opening remarks at the COVID-19 media briefing– 12 July 2022
COVID-19 - guidance for health protection teams (HPTs) - version 2.4 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Statement on the twelfth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
COVID-19 Contact tracing: country experiences and way forward
Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines
ECDC and EMA update recommendations on additional booster doses of COVID-19 vaccines
COVID-19 Scientific and Public Health Policy Update – (06 July 2022) – Africa CDC
Outbreak Brief 129: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Information about COVID-19 at Edmonton Institution for Women - Canada.ca
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 22 June 2022 - GOV.UK
Interim guidance on the use of rapid antigen detection tests for the identification of SARS-CoV-2 infection - Canada.ca
Information about COVID-19 at Dorchester Penitentiary - Canada.ca
Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022 | MMWR
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5–11 years in Italy - ISS
COVID-19 Vaccine Access in Long-term Care Settings | CDC
WHO Director-General's opening remarks at the Member State Information Session on COVID-19 and other issues
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 6 July 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
WHO Director-General's opening remarks at 11th ACT-A Facilitation Council - 6 July 2022
WHO Director-General's opening remarks at the COVID-19 media briefing – 6 July2022
Contact tracing and quarantine in the context of COVID-19: interim guidance, 6 July 2022
Moderna COVID-19 Vaccine's Reactions and Adverse Events | CDC
COVID-19 was third leading cause of death in the United States in both 2020 and 2021 | National Institutes of Health (NIH)
Changes to the severity of COVID-19 and impact on hospitals in Scotland, January-April 2022 - Changes to the severity of COVID-19 and impact on hospitals in Scotland - Publications - Public Health Scotland
How Jurisdictions Can Ensure COVID-19 Vaccine Access for Staff and Residents in Long-term Care Settings | CDC
A systematic approach to monitoring and analysing public health and social measures in the context of the COVID-19 pandemic: underlying methodology and application of the PHSM database and PHSM Severity Index: updated July 2022
Catalonia ensures COVID-19 vaccine interventions leave no community behind
Coronavirus disease (COVID-19): Home care for families and caregivers
Outbreak Brief 128: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
ECDC-WHO/Europe COVID-19 Surveillance Explorer
Vaccine update: issue 330, June 2022, COVID-19 spring special edition - GOV.UK
Outbreak Brief 127: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Enabling Hotspot Detection and Public Health Response to the COVID-19 Pandemic
COVID-19 Vaccine Provider Availability and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 1, 2021–April 25, 2022 | MMWR
Statement from the Chief Public Health Officer of Canada on June 30, 2022 - Canada.ca
Join the WHO/Europe #DoItAll campaign
Strengthening the health system response to COVID-19
Reaching the unreached with COVID-19 vaccination across the Western Pacific Region
Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months–5 Years — United States, June 2022 | MMWR
Evaluation of the flu and COVID-19 vaccination programmes in Scotland - interim report (November 2021) - Evaluation of the flu and COVID-19 vaccination programmes in Scotland - interim report (November 2021) - Publications - Public Health Scotland
11th ACT-Accelerator Facilitation Council meeting
Summary of evidence supporting COVID-19 public health measures - Canada.ca
Q&A: How to combat the infodemic with digital solutions to reduce health risks during the COVID-19 pandemic and beyond
COVID-19 variants identified in the UK – latest updates - GOV.UK
CDC Recommends Moderna COVID-19 Vaccine for Children and Adolescents | CDC Online Newsroom | CDC
HIV Testing Before and During the COVID-19 Pandemic — United States, 2019–2020 | MMWR
Clinical management of COVID-19: Living guideline, 23 June 2022
Weekly national seasonal respiratory report - Week 24 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland
Download historical data (to 20 June 2022) on the weekly number of new reported COVID-19 cases and deaths worldwide
COVID-19 Vaccination – Africa CDC
COVID-19 information and guidance for workplaces and community settings- version 1.2 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland
ACT-Accelerator: Quarterly Update Q1: 1 January – 31 March 2022
Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–Level Social Vulnerability — United States, December 23, 2021–May 21, 2022 | MMWR
Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022 | MMWR
Monthly operational update on COVID-19 - June 2022
COVID-19 - guidance for health protection teams (HPTs) - version 2.3 - COVID-19 - guidance for health protection teams (HPTs) - Publications - Public Health Scotland
Understanding Viral Vector COVID-19 Vaccines | CDC
Ways Health Departments Can Help Increase COVID-19 Vaccinations | CDC
COVID-19 vaccines and medicines: updates for June 2022 - GOV.UK
SIREN study - GOV.UK
Uptake of spring booster encouraged as COVID-19 cases rise across Scotland - News - Public Health Scotland
Equity in Childhood COVID-19 Vaccination
WHO Director-General's remarks at press conference following G20 Health Ministers Meeting – 20 June 2022
Customizable Content for School and Childcare-Located Vaccination Clinics | CDC
COVID-19 Vaccination Interim Clinical Considerations FAQs | CDC
Quick Conversation Guide on COVID-19 Vaccines for Children | CDC
An early-warning tool for the spread of COVID-19 and other health threats
Infection prevention and control (IPC) educational resources - COVID-19 health protection guidance - COVID-19 - Our areas of work - Public Health Scotland
COVID Alert: Canada's exposure notification app - Canada.ca
Statement from the Chief Public Health Officer of Canada on June 17, 2022 - Canada.ca
Interim statement on decision-making considerations for the use of variant updated COVID-19 vaccines
Interim statement on the composition of current COVID-19 vaccines
Outbreak Brief 126: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Notes from the Field: COVID-19–Associated Mortality Risk Among Long-Term Care Facility Residents and Community-Dwelling Adults Aged ≥65 Years — Illinois, December 2020 and January 2022 | MMWR
WHO Director-General's remarks at the IX Baku Forum – 17 June 2022
Tonnes of COVID-19 health care waste expose urgent need to improve waste management systems
WHO mass gathering COVID-19 risk assessment tool: generic events, version 3
WHO consultation to adapt influenza sentinel surveillance systems to include COVID-19 virological surveillance: virtual meeting, 6 – 8 October 2020
Coronavirus disease (COVID-19) pandemic
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 15 June 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Digital solutions to health risks raised by the COVID-19 infodemic. Synthesis Report
Vaccine Taskforce to merge with UKHSA and OLS - GOV.UK
COVID-19 Data and Surveillance Reporting Updates: June 2022 | Public Health Ontario
CDC Requirements for Immigrant Medical Examinations: COVID-19 Technical Instructions for Panel Physicians | Immigrant and Refugee Health | CDC
Suspension of the mandatory vaccination requirement for domestic travellers and federally regulated transportation workers - Canada.ca
Backgrounder: Government of Canada suspends mandatory vaccination for federal employees - Canada.ca
Suspension of the vaccine mandates for domestic travellers, transportation workers and federal employees - Canada.ca
COVID-19 guidance for prison settings - version 2 - COVID-19 guidance for prison settings - Publications - Public Health Scotland
SARS-CoV-2 in children
Implications of the emergence and spread of the SARS-CoV-2 variants of concern BA.4 and BA.5 for the EU/EEA
Highest-risk patients eligible for COVID-19 treatments: guide for patients - GOV.UK
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 25 May 2022 - GOV.UK
COVID-19 and HIV | HIV Basics | HIV/AIDS | CDC
CDC Rescinds Order Requiring Negative Pre-Departure COVID-19 Test Prior to Flight to the US | CDC Online Newsroom | CDC
IANPHI COVID-19 Webinar Series | IANPHI
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 8 June 2022 - Repository - Public Health Scotland
COVID-19 Vaccination Coverage, by Race and Ethnicity — National Immunization Survey Adult COVID Module, United States, December 2020–November 2021 | MMWR
Ventilation Improvement Strategies Among K–12 Public Schools — The National School COVID-19 Prevention Study, United States, February 14–March 27, 2022 | MMWR
COVID-19 Case Management Webinar Series: Care of the critical patient
£7 billion for NHS and social care for COVID-19 response and recovery - GOV.UK
Preliminary Report for the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO)
COVID-19 vaccination efforts prove value of polio network for resilient health systems
Disease surveillance reports
COVID-19 surveillance and immunity studies up to March 2022 - GOV.UK
Hospital onset COVID-19 mortality in Scotland - 7 March 2020 to 31 March 2022 - Hospital onset COVID-19 mortality in Scotland - Publications - Public Health Scotland
Questions and answers on COVID-19: Current situation in the EU
COVID-19 Cases, Hospitalizations, and Deaths Among American Indian or Alaska Native Persons — Alaska, 2020–2021 | MMWR
Interim statement on hybrid immunity and increasing population seroprevalence rates
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 11 May 2022 - GOV.UK
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 15 May 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
How has the COVID-19 pandemic affected children and young people in Scotland? - News - Public Health Scotland
Outbreak Brief 125: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
ECDC issues guidance on scaling up capability and capacity to characterise SARS-CoV-2 variants
Maintaining infection prevention and control measures for COVID-19 in health care facilities: Policy brief, 7 June 2022
Defining the highest-risk clinical subgroups upon community infection with SARS-CoV-2 when considering the use of neutralising monoclonal antibodies (nMABs) and antiviral drugs: independent advisory group report
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 May 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
COVID-19 Scientific and Public Health Policy Update – (25 May 2022) – Africa CDC
Mobilizing young people to promote vaccination against COVID-19 in the Republic of Moldova
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine
Technical guidance for antigenic SARS-CoV-2 monitoring
Severity of disease associated with Omicron variant as compared with Delta variant in hospitalized patients with suspected or confirmed SARS-CoV-2 infection
Infection Prevention and Control Assessment Tool for Nursing Homes Preparing for COVID-19 | HAI | CDC
NERVTAG and EMG: Role of aerosol transmission in COVID-19 - 22 July 2020 - GOV.UK
CDC launches Traveler-based SARS-CoV-2 Genomic Surveillance Program | Advanced Molecular Detection (AMD) | CDC
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 1 June 2022 - Repository - Public Health Scotland
Outbreak Brief 123: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
COVID-19 in Newly Resettled Refugee Populations | Immigrant and Refugee Health | CDC
COVID-19 vaccine tracker and landscape
Sinopharm [Vero Cell]- Inactivated, COVID-19 vaccine
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 25 May 2022 - Repository - Public Health Scotland
Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021 | MMWR
Understanding the behavioural and social drivers of vaccine uptake WHO position paper – May 2022
UKHSA expands support to help countries identify emerging variants - GOV.UK
Joint Committee on Vaccination and Immunisation (JCVI) interim statement on the COVID-19 vaccination programme for autumn 2022 - GOV.UK
COVAX calls for urgent action to close vaccine equity gap
CDC Strengthens Recommendations and Expands Eligibility for COVID-19 Booster Shots | CDC Online Newsroom | CDC
Interim recommendations for use of the Cansino Ad5-nCoV-S vaccine (Convidecia ®) against COVID-19
JCVI provides interim advice on an autumn COVID-19 booster programme - GOV.UK
Interim Guidance for Ships on Managing Suspected or Confirmed Cases of Coronavirus Disease 2019 (COVID-19) | Quarantine | CDC
Coronavirus Disease 2019 (COVID-19) - Variant of Concern Screening and Whole Genome Sequencing Surveillance | Public Health Ontario
WHO validates 11th vaccine for COVID-19
COVID-19 Aviation Health Safety Protocol: Operational guidelines for the management of air passengers and aviation personnel in relation to the COVID-19 pandemic
COVID-19: epidemiology, virology and clinical features - GOV.UK
COVID-19 Scientific and Public Health Policy Update – (11 May 2022) – Africa CDC
CDC COVID-19 Global Response | CDC
EMRG medium-term projections for COVID-19 hospitalisations and deaths: 27 April 2022 - GOV.UK
Coronavirus disease (COVID-19): Vaccines
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 11 May 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Outbreak Brief 121: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
WHO Director-General's live speech at 2nd Global COVID Summit – 12 May 2022
European COVID-19 reference laboratory network (ECOVID-LabNet)
Monitoring reports of the effectiveness of COVID-19 vaccination - GOV.UK
National protocol for Vaxzevria COVID-19 Vaccine (ChAdOx1-S [recombinant]) - GOV.UK
Africa CDC Releases New Country Research on Scale-Up of COVID Vaccines – Africa CDC
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 1 June 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Kyrgyzstan: leveraging SARI surveillance to monitor vaccine effectiveness
COVID-19 information and guidance for workplaces and community settings- version 1.1 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland
Statement from the Chief Public Health Officer of Canada on May 6, 2022 - Canada.ca
Communicable disease threats report, 1-7 May 2022, week 18
Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant — United States, February 14–March 27, 2022 | MMWR
Global excess deaths associated with COVID-19 (modelled estimates)
Methods for estimating the excess mortality associated with the COVID-19 pandemic
Coronavirus (COVID-19) testing for hospices - GOV.UK
Outbreak Brief 120: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Ultra-low temperature vaccine management | OpenWHO
Pacific Community-Led Health Missions Arrive with Critical Support to Tonga and Kiribati Grappling with COVID-19 Surges | The Pacific Community
International Workshop on COVID-19 Lessons to Inform Pandemic Influenza Response: Proceedings of a Workshop
CDC Recommendation for Masks and Travel | CDC Online Newsroom | CDC
UKHSA data series on deaths in people with COVID-19: technical summary - GOV.UK
Questions and answers on COVID-19: Travelling
COVID-19: epidemiological update. Weekly report. Week 16. 28 April 2022.
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 4 May 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 10 April 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Communicable disease threats report, 24-30 April 2022, week 17
COVID-19 vaccine uptake in healthcare workers: explainer - GOV.UK
A second booster could avert a substantial proportion of COVID-19 deaths between now and mid-autumn 2022 in older age groups
Public health considerations and evidence to support decisions on the implementation of a second mRNA COVID-19 vaccine booster dose
Weekly national seasonal respiratory report - Week 16 2022 - Weekly national seasonal respiratory report - Publications - Public Health Scotland
COVID-19 Data and Surveillance Reporting Updates | April 27 | Public Health Ontario
Transitioning beyond the acute phase of the COVID-19 pandemic: Approaches and tools used by a sample of EU countries in the transition and de-escalation phase – interim report
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 3 April 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 27 April 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Outbreak Brief 119: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
CDC Media Telebriefing: Update on COVID-19 | CDC Online Newsroom | CDC
The ACT-Accelerator: Two years of impact
Report of the High-Level Ministerial Meeting | Partnerships to Accelerate COVID-19 Vaccination in Africa – Africa CDC
Questions and answers on COVID-19: Basic facts
Sinovac CoronaVac® [Vero Cell]- Inactivated, COVID-19 vaccine
Solidarity Trial Vaccines
Remarks from the Chief Public Health Officer, April 22, 2022. - Canada.ca
COVID-19 Was Third Leading Cause of Death in U.S. | CDC Online Newsroom | CDC
Accelerating COVID-19 Vaccine Deployment
Outbreak Brief 118: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Communicable disease threats report, 17-23 April 2022, week 16
Hospitalizations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 | MMWR
Provisional COVID-19 Age-Adjusted Death Rates, by Race and Ethnicity — United States, 2020–2021 | MMWR
COVID-19 vaccines and medicines: updates for April 2022 - GOV.UK
COVID-19 information and guidance for workplaces and community settings - version 1.0 - COVID-19 information and guidance for workplaces and community settings - Publications - Public Health Scotland
People who are at risk of more severe disease or outcomes from COVID-19 - Canada.ca
Summary of Product Characteristics Comirnaty 30 micrograms/dose concentrate (purple cap) - GOV.UK
Consolidated report of country success stories in mitigating the impact of the COVID-19 pandemic on TB services
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 27 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 20 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 20 April 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 13 April 2022 - Repository - Public Health Scotland
COVID-19 treatments - Canada.ca
COVID-19: Vaccine safety and side effects - Canada.ca
Societal Experts Action Network: Strategies for Communicating with People Who Are Not Vaccinated to Build Confidence in Covid-19 Vaccines | The National Academies Press
Patient Information Leaflet for Comirnaty 10 micrograms/dose concentrate (orange cap) - GOV.UK
COVID-19 Mortality and Vaccine Coverage — Hong Kong Special Administrative Region, China, January 6, 2022–March 21, 2022 | MMWR
Health Canada authorizes Evusheld for the prevention of COVID-19 in immune compromised adults and children - Canada.ca
Environmental surveillance for SARS-COV-2 to complement public health surveillance – Interim Guidance
COVID-19 Emergency ICD Codes
Vaccinating Children with Disabilities Against COVID-19 | CDC
Statement on the eleventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic
Statement from the Chief Public Health Officer of Canada on April 12, 2022 - Canada.ca
Effectiveness of COVID-19 mRNA Vaccination in Preventing COVID-19–Associated Hospitalization Among Adults with Previous SARS-CoV-2 Infection — United States, June 2021–February 2022 | MMWR
WHO Director-General's opening remarks at the Public Hearing regarding a new international instrument on pandemic preparedness and response – 12 April 2022
Immunization, Vaccines and Biologicals
COVID-19 IHR Emergency Committee
WHO Director-General's opening remarks at the 11th meeting of the Emergency Committee for COVID-19 – 11 April 2022
Stopping TB infection in children
Scientific and strategic talks on COVID-19 | OpenWHO
COVID-19: epidemiological update. Weekly report. Week 13. 7 April 2022.
COVID-19: Outbreak update - Canada.ca
Communicable disease threats report, 3-9 April 2022, week 14
Clinical care of severe acute respiratory infections – Tool kit
Video: ECDC Director on fourth doses of mRNA COVID-19 vaccines
Notes from the Field: SARS-CoV-2 Omicron Variant Infection in 10 Persons Within 90 Days of Previous SARS-CoV-2 Delta Variant Infection — Four States, October 2021–January 2022 | MMWR
COVID-19 - information and guidance for care home settings (for older adults) - COVID-19 - information and guidance for care home settings (for older adults) - Publications - Public Health Scotland
The need for linked genomic surveillance of SARS-CoV-2, CCDR 48(4) - Canada.ca
Outbreak Brief 116: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Prevalence of COVID-19 remains at high levels across the country - GOV.UK
Therapeutics and COVID-19
Statement from the Council of Chief Medical Officers of Health (CCMOH) on the importance of staying up to date with COVID-19 vaccines - Canada.ca
Antibodies recognize new SARS-CoV-2 Omicron variant after booster | National Institutes of Health (NIH)
COVID-19 highest risk programme - COVID-19 data and intelligence - COVID-19 - Our areas of work - Public Health Scotland
WHO warns of a surge in COVID-19 cases if unsafe gatherings continue
The Janssen COVID-19 Vaccine's Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events | CDC
UK COVID-19 Inquiry: draft terms of reference (HTML) - GOV.UK
Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 | MMWR
WHO's response to COVID-19 - 2021 Annual Report
COVID-19 and people with disabilities in Canada - Canada.ca
Johnson & Johnson's Janssen COVID-19 Vaccine Overview and Safety | CDC
COVID-19: guidance for people whose immune system means they are at higher risk - GOV.UK
Government of Canada launches second cycle of national survey to assess the health impacts of the COVID-19 pandemic - Canada.ca
Suspension of supply of COVID-19 vaccine (COVAXIN®)
WHO supports regions to increase COVID-19 vaccination uptake among seniors, indigent population
What Clinicians Need to Know About Pfizer-BioNTech COVID-19 Vaccination of Adolescents
COVID-19 vaccine update for employees: May 20, 2022 - Canada.ca
COVID-19: Use ArriveCAN to enter Canada - Canada.ca
Lessons Learned from National Public Health Institutes' Response to the COVID-19 Outbreak in 2020 | IANPHI
Statement for healthcare professionals: How COVID-19 vaccines are regulated for safety and effectiveness
Cansino Ad5-nCoV-S vaccine recommendations for use
Results from a Test-to-Release from Isolation Strategy Among Fully Vaccinated National Football League Players and Staff Members with COVID-19 — United States, December 14–19, 2021
Investigation of SARS-CoV-2 Transmission Associated With a Large Indoor Convention — New York City, November–December 2021
SARS-CoV-2 B.1.1.529 (Omicron) Variant Transmission Within Households — Four U.S. Jurisdictions, November 2021–February 2022
Pediatric Emergency Department Visits Before and During the COVID-19 Pandemic — United States, January 2019–January 2022
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022
Variants: distribution of case data, 1 April 2022 - GOV.UK
Using the NHS COVID Pass to demonstrate COVID-19 status - GOV.UK
Coronavirus Disease 2019 (COVID-19) – Serology | Public Health Ontario
NIH experts discuss controlling COVID-19 in commentary on herd immunity | National Institutes of Health (NIH)
Promoting the health of refugees and migrants during COVID-19 pandemic
Interim statement on the use of additional booster doses of Emergency Use Listed mRNA vaccines against COVID-19
Singapore and the African Union can digitally verify each other's COVID-19 Vaccination Certificates from 23 May 2022 – Africa CDC
WHO Director-General's opening remarks at the COVID-19 media briefing– 17 May 2022
Outbreak Brief 122: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Statement from the Chief Public Health Officer of Canada on April 1, 2022 - Canada.ca
Infection prevention and control in the context of coronavirus disease (COVID-19): A living guideline
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022 | MMWR
Q&A on Myocarditis and Covid-19 Vaccines
COVID-19: Joint statement from ECDC and EMA on the administration of a fourth dose of mRNA vaccines
COVID-19 vaccine: Canadian Immunization Guide - Canada.ca
Coronavirus disease (COVID-19)
COVID-19 - information and guidance for social, community and residential care settings - version 2.1 - COVID-19 - information and guidance for social, community and residential care settings - Publications - Public Health Scotland
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 30 March 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 6 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Coronavirus disease (COVID-19): Children and masks
Outbreak Brief 115: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Weekly operational update on COVID-19 - 30 March 2022
Almost 80% of eligible over-75s receive spring booster - GOV.UK
Epidemiological update on SARS-CoV-2 Omicron sub-lineages BA.4 and BA.5
Digital Response for connecting Citizens- "Supporting the Pacific Close the Digital Divides in Response to COVID-19" | The Pacific Community
Coronavirus disease (COVID-19): Pregnancy, childbirth and the postnatal period
NHS COVID-19 app
Coronavirus (COVID-19) Infection Survey technical article: cumulative incidence of the number of people who have tested positive for COVID-19 - GOV.UK
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 13 March 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Coronavirus (COVID-19) testing for adult social care services - GOV.UK
Weekly epidemiological update on COVID-19 - 29 March 2022
European Union funding boosts COVID-19 vaccination in Africa
Summary of Product Characteristics for Nuvaxovid dispersion for injection - GOV.UK
Summary of Product Characteristics for Spikevax - GOV.UK
Changes to COVID-19 testing in England from 1 April - GOV.UK
Pregnant women urged to come forward for COVID-19 vaccination - GOV.UK
Variants: distribution of case data, 6 May 2022
Patient Information Leaflet Comirnaty 30 micrograms/dose concentrate (purple cap) - GOV.UK
Coronavirus disease (COVID-19): Vaccines safety
EASA and ECDC take first steps to relax COVID-19 measures for air travel
Thailand shares lessons learned from the COVID-19 pandemic with WHO
COVID-19 statistical report - 11 May 2022 - COVID-19 statistical report - Publications - Public Health Scotland
Hospital onset COVID-19 cases in Scotland - Week ending 01 March 2020 to week ending 17 April 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
COVID-19: For travellers with symptoms, a positive test, who aren't fully vaccinated without symptoms, or who don't have a fully vaccinated exemption - Canada.ca
Statement from the Chief Public Health Officer of Canada on March 25, 2022 - Canada.ca
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 27 February 2022 - Hospital onset COVID-19 cases in Scotland - Publications - Public Health Scotland
Use of At-Home COVID-19 Tests — United States, August 23, 2021–March 12, 2022 | MMWR
COVID-19 vaccination: guide for employers - GOV.UK
Decarcerating Correctional Facilities during COVID-19: Advancing Health, Equity, and Safety: Report Overview | The National Academies Press
Patient Information Leaflet for Spikevax - GOV.UK
WHO and MPP announce the first transparent, global, non-exclusive licence for a COVID-19 technology
COVID-19 variants identified in the UK - GOV.UK
Update 76 – Masks in the context of COVID-19
Strengthening COVID-19 vaccine demand and uptake in refugees and migrants
Communicable disease threats report, 20-26 March 2022, week 12
Increasing Uptake of COVID-19 Vaccination Through Requirement and Incentive Programs | National Academies Press
14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021
UTTAR PRADESH Going the last mile to stop COVID-19
COVID-19 confirmed deaths in England (to 31 March 2022): report - GOV.UK
Tuberculosis in the time of COVID-19
Reducing the spread of respiratory infections, including COVID-19, in the workplace
Effect of COVID-19 on Tuberculosis in the U.S. | CDC Online Newsroom | CDC
Global research on coronavirus disease (COVID-19)
WHO recommends highly successful COVID-19 therapy and calls for wide geographical distribution and transparency from originator
Pfizer-BioNTech COVID-19 Vaccine Overview and Safety | CDC
Over half of pregnant women have now had one or more doses of COVID-19 vaccines - GOV.UK
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022 | MMWR
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022 | MMWR
Weekly epidemiological update on COVID-19 - 12 April 2022
Quarantine and Isolation
Weekly national seasonal respiratory report - Week ending 20 March 2022 - week 11
Information about COVID-19 at Mountain Institution - Canada.ca
Mitigating the COVID-19 outbreak through global data sharing
Outbreak Brief 114: Coronavirus Disease 2019 (COVID-19) Pandemic – Africa CDC
Press Release N°36/2021 COVID-19: The vaccine affords up to 100% protection against infections, hospitalization and death - ISS
WHO Director-General's opening remarks at the WHO press conference – 23 March 2022
Enhanced Surveillance of COVID-19 in Scotland - Population-based seroprevalence surveillance 23 March 2022 - Enhanced Surveillance of COVID-19 in Scotland - Publications - Public Health Scotland
Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern
How CDC Determines the Level for COVID-19 Travel Health Notices | CDC
UKHSA review shows vaccinated less likely to have long COVID than unvaccinated - GOV.UK
Flying in the COVID-19 Era: Science-based Risk Assessments and Mitigation Strategies on the Ground and in the Air: Proceedings of a Workshop
COVID-19 pandemic: testing capacities grow manifold in WHO South-East Asia Region, focus now on enhancing genome sequencing
The Pfizer BioNTech (BNT162b2) COVID-19 vaccine: What you need to know
Diagnostic testing and screening for SARS-CoV-2
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 20 February 2022
Preventing and controlling outbreaks of COVID-19 in prisons and places of detention - GOV.UK
Mandatory masking in schools reduced COVID-19 cases | National Institutes of Health (NIH)
Infection prevention and control in adult social care: COVID-19 supplement
Enhanced Surveillance of COVID-19 in Scotland
COVID-19 Resource Centre
To avert a learning catastrophe, schools must stay open amidst Omicron threat and beyond
Weekly operational updates on COVID-19 - 22 March 2022
Weekly epidemiological update on COVID-19 - 22 March 2022
Weekly epidemiological update on COVID-19 - 5 April 2022
Interim guidance on COVID-19 Rapid Antigen self-testing to African Union Member States
Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022
COVID-19 respiratory equipment
Weekly epidemiological update on COVID-19 - 1 March 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022
Maintaining essential health services during the COVID-19 outbreak
Report of the WHO global technical consultation on public health and social measures during health emergencies
An ad hoc WHO technical consultation managing the COVID-19 infodemic: call for action
Report of the Regional Director : the work of WHO in the Western Pacific Region, 1 July 2019 - 30 June 2020
COVAX No-Fault Compensation Program
COVID-19 vaccine country readiness and delivery
Transcript for CDC Media Telebriefing: Update on COVID-19
COVID-19 Community Levels - A measure of the impact of COVID-19 illness on health and healthcare systems
CDC Media Telebriefing: Update on COVID-19
Strengthening resilience among migrants impacted by COVID-19
Communicable disease threats report, 20-26 February 2022, week 8
Antigen Test Positivity After COVID-19 Isolation — Yukon-Kuskokwim Delta Region, Alaska, January–February 2022
Use of COVID-19 Vaccines in the United States
COVID-19: For persons exempt from entry prohibitions, and quarantine and testing requirements
Coronavirus disease (COVID-19): Employee illness and leave requests
Disparities in COVID-19 Vaccination Coverage Between Urban and Rural Counties — United States, December 14, 2020–January 31, 2022
Hospital onset COVID-19 mortality in Scotland - 7 March 2020 to 31 December 2021
COVID-19 - information and guidance for social, community and residential care settings
Hospital onset COVID-19 cases in Scotland
COVID-19: Requirements for fully vaccinated travellers and unvaccinated children less than 12 years of age
COVID-19 Vaccines
Rapid review on protective immunity post infection with SARS-CoV-2: update 3
Pfizer-BioNTech COVID-19 Vaccine (Gray Cap) Age 12 and Over
Hospital onset COVID-19 cases in Scotland - Week ending 1 March 2020 to week ending 30 January 2022
COVID-19 reporting to include further data on reinfections
COVID-19 statistical report as at 21 February 2022
WHO Pharmaceuticals Newsletter - N°1, 2022
Outbreak Brief 110: Coronavirus Disease 2019 (COVID-19) Pandemic
Statement from the Chief Public Health Officer of Canada on February 18, 2022
Covid-19: Scientists and medics warn that it is too soon to lift all restrictions in England
Rapid lateral flow coronavirus (COVID-19) tests
Weekly national seasonal respiratory report - WWeek ending 13 February 2022 - week 6
COVID-19 Resources for Members and Global Public Health Professionals
Treatment and pharmaceutical prophylaxis of COVID-19
WHO announces first technology recipients of mRNA vaccine hub with strong support from African and European partners
Communicable disease threats report, 13-19 February 2022, week 7
Coronavirus: how to stay safe and help prevent the spread
COVID-19 - WHO Thailand Situation Reports
Partnership to Accelerate COVID-19 Testing: Scaling up Rapid Antigen Self-testing
Pediatric Emergency Department Visits Associated with Mental Health Conditions Before and During the COVID-19 Pandemic — United States, January 2019–January 2022
COVID-19 vaccines
Remarks from the Chief Public Health Officer on Feb 11, 2022
Press Release N° 34/2021 COVID-19: in Italy the Delta variant increased in June reaching 16.8%, while the rampant variant is the English variant (74.92%)
Multistate Outbreak of SARS-CoV-2 B.1.1.529 (Omicron) Variant Infections Among Persons in a Social Network Attending a Convention — New York City, November 18–December 20, 2021
Scientists pinpoint mechanisms associated with severe COVID-19 blood clotting
Notes from the Field: Outbreak of COVID-19 Among a Highly Vaccinated Population Aboard a U.S. Navy Ship After a Port Visit — Reykjavik, Iceland, July 2021
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) - Recent Work
COVID-19: reducing outbreak risk with repeated antigen screening in healthcare facilities
Hospitalizations of Children and Adolescents with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, July 2021–January 2022
Government of Canada lightens border measures as part of transition of the pandemic response
CDC Experts and Partners Unite to Respond to Haiti Earthquake Amidst COVID-19 Pandemic
A-Z Index Advanced Search Global Health Protection and Security - Message from the Director
Innovative genomic data analysis method leads to the discovery of novel coronavirus families
Enhanced Surveillance of COVID-19 in Scotland - 02 March 2022
Enhanced Surveillance of COVID-19 in Scotland - 16 March 2022
Outbreak Brief 111: Coronavirus Disease 2019 (COVID-19) Pandemic
UK scales back routine covid-19 surveillance
Know Your COVID-19 Community Level
UKRAINE | Online courses in Ukrainian support national response to the COVID-19 pandemic and other emergencies
Communicable disease threats report, 27 February - 5 March 2022, week 9
March 2022 - Emerging Infectious Diseases Journal
Impact of the COVID-19 pandemic on seven neglected tropical diseases: a model-based analysis
WHO updates its treatment guidelines to include molnupiravir
Transmission of SARS-CoV-2 from mother to baby is rare, say researchers
Weekly national seasonal respiratory report- Week ending 13 March 2022 - week 10
Covid-19: Doctors urge government to step up on global vaccine funding
Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine (Regulation 174)
Communicable disease threats report, 13-19 March 2022, week 11
COVID-19–Associated Hospitalizations Among Adults During SARS-CoV-2 Delta and Omicron Variant Predominance, by Race/Ethnicity and Vaccination Status — COVID-NET, 14 States, July 2021–January 2022
Effectiveness of mRNA Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022
Operational public health considerations for the prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine
Prevention and control of infectious diseases in the context of Russia’s aggression towards Ukraine
COVID-19 vaccination programme for children and young people: guidance for parents (version 3)
Mental health in emergencies
Hospitalization of Infants and Children Aged 0–4 Years with Laboratory-Confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022
COVID-19 vaccine information and resources
WHO released a new operational guide to promote COVID-19 vaccination uptake and tackle vaccine hesitancy among refugees and migrants
Global Health Emergency Appeal 2022
Outbreak Brief 109: Coronavirus Disease 2019 (COVID-19) Pandemic
Preview Posting of COVID-19 Vaccine Codes and Crosswalk for Currently Authorized Vaccines and Anticipation of Potential Vaccine Availability under Emergency Use Authorization (EUA)
Evusheld approved to prevent COVID-19 in people whose immune response is poor
COVID-19 testing, vaccination and implementation of protective measures recommended for reception centres of displaced people from Ukraine
True extent of SARS-CoV-2 Infection through seroprevalence studies
Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield)
Preventing or limiting the spread of COVID-19 on cruise ships
Prime Minister sets out plan for living with COVID
The R value and growth rate
Coronavirus (COVID-19) test kits for children's homes
COVID-19 content collection
SARS-CoV-2 Incidence in K–12 School Districts with Mask-Required Versus Mask-Optional Policies — Arkansas, August–October 2021
COVID-19 Scientific and Public Health Policy Update – (2 March 2022)
Pandemic Protection
Weekly epidemiological update on COVID-19 - 8 March 2022
COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022
Outbreak Brief 112: Coronavirus Disease 2019 (COVID-19) Pandemic
COVID-19 Management Archives – Africa CDC
Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness — United States and Puerto Rico, April 2020–March 2021
Talking Points, Weekly Press Briefing on COVID-19 in Africa, 10 March 2022
Mandatory masking in schools reduced COVID-19 cases during Delta surge
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022
COVID-19: Pacific Community Updates | The Pacific Community
Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)
Statement on Omicron sublineage BA.2
COVID-19 statistical report - As at 15 March 2022
Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine
Outbreak Brief 113: Coronavirus Disease 2019 (COVID-19) Pandemic
Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults
Strengthening Health Services for COVID-19 Response in Kiribati
Coronavirus disease (COVID-19): Ventilation and air conditioning
Weekly national seasonal respiratory report - Week ending 6 March 2022 - week 9
Coronavirus vaccine - weekly summary of Yellow Card reporting
COVID-19 advice for the public: Getting vaccinated
Pfizer-BioNTech Comirnaty COVID-19 vaccine
National flu and COVID-19 surveillance reports published
Communicable disease threats report, 6-11 March 2022, week 10
ASPHER statement marking two years of the COVID-19 pandemic
All COVID-19 travel restrictions removed in the UK
Webinars on COVID-19
Infographics, posters and leaflets about COVID-19
Eighth Meeting of the Multilateral Leaders Task Force on COVID-19, 1 March 2022: "Third Consultation with the CEOs of leading vaccine manufacturers"
Download COVID-19 datasets
COVID-19 vaccination
Guidance for the prevention and control of COVID-19 in temporary reception centres in the context of the large numbers of people fleeing Ukraine
WHO advises that ivermectin only be used to treat COVID-19 within clinical trials
SARS-CoV-2 variants dashboard
Technical Instructions for CDC’s COVID-19 Program for Cruise Ships Operating in U.S. Waters
Evaluation of the SARS-CoV-2 testing policy in Belgium from June to December 2021
Infection
WHO consultation on COVID-19 vaccines research - Advancing the development of pan-sarbecovirus vaccines
Environmental Health Strategies to Reduce COVID-19
Data collection on COVID-19 outbreaks in closed settings: long-term care facilities, version 2.1
Getting a COVID-19 Vaccine
Covid-19: Evusheld is approved in UK for prophylaxis in immunocompromised people
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Tracking SARS-CoV-2 variants
COVID-19: Making vaccination decisions for children 5 to 11 years of age
Guidance for people previously considered clinically extremely vulnerable from COVID-19
Statement from the Chief Public Health Officer of Canada on March 11, 2022
COVID-19 by County
COVID-19 statistical report as at 28 February 2022
Coronavirus disease (COVID-19): Masks
COVID-19: track coronavirus cases
Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update
Weekly epidemiological update on COVID-19 - 15 March 2022
Weekly operational update on COVID-19 - 15 March 2022
COVID-19: people with COVID-19 and their contacts
Videos on COVID-19
The Global Health Observatory
